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ABSTRACT
Motivation: The NanoString nCounter Platform is a new and
promising technology for measuring nucleic acid abundances. It
has several advantages over PCR-based techniques, including
avoidance of ampliﬁcation, direct sequence interrogation and digital
detection for absolute quantiﬁcation. These features minimize
aspects of experimental error and hold promise for dealing with
challenging experimental conditions such as archival formalin-
ﬁxed parafﬁn-embedded samples. However, systematic inter-sample
technical artifacts caused by variability in sample preservation, bio-
molecular extraction and platform ﬂuctuations must be removed to
ensure robust data.
Results: To facilitate this process and to address these issues for
NanoString datasets, we have written a pre-processing package
called NanoStringNorm in the R statistical language. Key features
include an extensible environment for method comparison and new
algorithm development, integrated gene and sample diagnostics,
and facilitated downstream statistical analysis. The package is open-
source, is available through the CRAN package repository, includes
unit-tests to ensure numerical accuracy, and provides visual and
numeric diagnostics.
Availability: http://cran.r-project.org/web/packages/NanoStringNorm
Contact: paul.boutros@oicr.on.ca
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
The NanoString nCounter Platform is an emerging medium-
throughput technology for measuring mRNA and miRNA
abundances and for assessing copy number variants (Geiss et al.,
2008). NanoString technology has several potential beneﬁts relative
to microarray- and PCR-based technologies. First, its parallelized
nature and small number of manual manipulations generate data
faster than many PCR-based methods. Second, the hybridization
method used directly interrogates target sequences, avoiding the
need for bias-prone ampliﬁcation steps, even for low-abundance
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transcripts. Third, measurement is achieved using digital detection
of uniquely bar-coded probes, providing absolute quantiﬁcation.
This combination of advantages is thought to provide favorable
conditions for testing formalin-ﬁxed parafﬁn-embedded (FFPE)
samples. FFPE preparation is a standard protocol for the long-
term storage of human clinical specimens. Despite some positive
reports (Hui et al., 2009), the degradation of RNAin FFPE samples
challenges existing mRNA quantitation assays. The ability to
reliably process FFPE samples would greatly facilitate retrospective
studies.
Accordingly there has been a dramatic increase in the uptake of
NanoString technology in our research facility. In some cases, it is
used as a validation procedure; in others as a discovery tool using
candidate genes. A common rationale is the desire to exploit large,
clinically well-annotated FFPE collections. Since NanoString is a
new technology, many details of its analysis remain unexplored:
optimal methods of data pre-processing are unknown, although this
iswell-knowntoimpactbiologicalconclusions(Shippyetal.,2006).
NanoString currently recommends pre-processing using
Microsoft Excel spreadsheet functions. This has signiﬁcant
limitations. First, manual analysis is both hard to reproduce
and prone to errors (McCullough and Heiser, 2006): gene- and
sample-name auto-formatting are well-known issues (Zeeberg
et al., 2004). Second, macros and worksheets cannot easily be
adapted to changing experimental designs or pre-processing
methods: spreadsheet software lacks the sophisticated statistical
tools common in bioinformatics (e.g. survival or mixed models).
Third, it is highly desirable to integrate workﬂows in a single
environment, and downstream analyses are typically performed in
statistical environments. Fourth, the quality of data pre-processing
requires careful assessment with data visualizations that are difﬁcult
to automate using spreadsheets.
For these reasons we have developed an open-source R package,
called NanoStringNorm, to implement a reference set of pre-
processing techniques. We chose the R statistical environment to
allow integration with BioConductor libraries (Gentleman et al.,
2004), and to exploit its data-visualization (Chen and Boutros,
2011) and statistical tools. NanoStringNorm outlines a pipeline
of pre-processing steps with multiple options at each stage and
provides a framework for method development and comparison. By
standardizing code and automating error capture, NanoStringNorm
will enable more reproducible and robust analysis of NanoString
datasets.
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2 IMPLEMENTATION
2.1 Pre-processing pipeline
NanoString provides analysis guidelines for miRNA and mRNA
assays online, which provide detailed instructions on options
available for pre-processing of the output of an nCounter. Pre-
processing involves ﬁve independent, but ordered, steps. Complete
equations for each algorithm are given in Supplementary Material.
2.2 Probe-level background correction
The ﬁrst step is not discussed in the NanoString guidelines, but it is
mentionedinnCounterdocumentation:duringsomeruns,probesare
ﬂagged for correction. Adjustment values are annotated in text ﬁles
which can be acquired from core facilities. Correction factors are
multiplied by the maximum positive control value, then subtracted
from the raw counts, per sample.
2.3 Code-count normalization
The second step accounts for lane-by-lane variation of the nCounter
platform. A series of exogenous probes of known concentration are
used, allowing observed variation to be attributed speciﬁcally to the
assay. Normalization occurs by summarizing (i.e. mean, median,
sum or geometric mean) the positive control counts and adjusting
samples by a factor relative to other samples.
2.4 Background correction
Even though data are presented as absolute counts, detectable levels
of non-speciﬁc binding remain, as measured by negative controls.
The background level is calculated as an aggregate summary of
six to eight control probes with no target transcript. The calculated
background level for each sample is then subtracted from the
adjustedprobevalue.Negativevaluesarescaledtozeroasabaseline
for no expression. The mean of negative controls is a non-stringent
correction that maximizes sensitivity in exchange for increased false
positives.Alternatively, the maximum or mean plus two SDs can be
used to prevent spurious results.
2.5 Sample content normalization
Sample RNA input variation is caused by laboratory and pipetting
anomalies independent of NanoString assay variation. Using
housekeeping genes is one common method of removing this bias.
For miRNAs and FFPE samples, it is often unclear how such genes
should be selected. Alternative approaches include summarizing
all genes, or focusing on a set of highly expressed genes. Sample
content normalization factors are calculated similar to code count
ones: a group of normalization genes is selected, summarized
(e.g. geometric mean, etc.) and a sample adjustment factor is
calculated.
2.6 Concentration prediction
A convenience function has been added to transform counts to
concentrations using positive controls: ﬁtting of positive control
concentrations is used to predict endogenous probe concentrations.
2.7 Best normalization
Toevaluatethebestpre-processingmethodforspeciﬁccodesetsand
study designs, a function was created to rank methods based on the
Fig. 1. NanoStringNorm volcano plot showing differential expression
caused by batch-effects between experiments on two days. Point-size reﬂects
mean counts per probe. Naive co-normalization introduces bias
coefﬁcient of variation of control probes, the intra-class correlation
ofreplicategroupsandthefoldchangeaccuracyforprimarytraitsof
interest.Thisfunctionissuitedforstudieswithtechnicalreplication,
such as titrations.
2.8 Software engineering decisions
The package is highly modular, to maximize extensibility. Gene and
sample summary plots and diagnostics (Fig. 1) are auto-generated
and ﬂag experimental artifacts. Unit-tests are continuously added to
diagnose and prevent numerical errors.
2.9 Visual and numeric diagnostics
We developed extensive diagnostics to enhance interpretation,
with a particular focus on experimental quality and reliability.
NanoStringNorm ﬂags potential systematic batch-effects, identiﬁes
background artifacts and assesses negative/positive-controls. Each
ﬂag is associated with plots (Supplementary Fig. S3) and all results,
diagnostics and differential expression can be output in interactive
Google motion charts (Supplementary Fig. S4).
3 RESULTS AND CONCLUSIONS
For a variety of reasons, NanoString usage is rising; making
standardized approaches to data analysis increasingly critical. We
have therefore developed an extensible, open-source R package
to automate pre-processing. Our package enables a wide range of
pre-processing approaches to be evaluated, and will be updated as
improved techniques are developed. For example, NanoString data
can be processed and statistically analyzed based on the negative
binomial distribution (Brumbaugh et al., 2011). Similar modeling,
integratedintotheNanoStringNormAPI,willmakeNanoStringdata
broadly useful for clinical applications. Future work will account for
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correlation among experimental design features such as replicates,
tissue subgroups and inter-experimental batch-effects.
ACKNOWLEDGEMENTS
We thank the Boutros lab for support and software testing.
Funding: Ontario Institute for Cancer Research (to P.C.B. and
B.G.W.); Ontario Ministry of Health and Long Term Care
(OMOHLTC; to B.G.W. and F.-F.L.); Dr Mariano Elia Chair in
Head & Neck Cancer Research; philanthropic support from the
Wharton family, Joe’s Team and Gordon Tozer. Views expressed
do not necessarily reﬂect those of the OMOHLTC.
Conﬂict of Interest: none declared.
REFERENCES
Brumbaugh,C.D. et al. (2011) Normalization and differential expression analysis of
NanoString nCounter data. BMC Bioinformatics, 12, 479.
Chen,H. and Boutros,P.C. (2011) VennDiagram: a package for the generation of highly
customizable Venn and Euler diagrams in R. BMC Bioinformatics, 12, 35.
Geiss,G.K. et al. (2008) Direct multiplexed measurement of gene expression with color-
coded probe pairs. Nat. Biotechnol., 26, 317–325.
Gentleman,R.C. et al. (2004) Bioconductor: open software development for
computational biology and bioinformatics. Genome Biol., 5, R80.
Hui,A.B.Y. et al. (2009) Robust global micro-RNA proﬁling with formalin-ﬁxed
parafﬁn-embedded breast cancer tissues. Lab. Invest., 89, 597–606.
McCullough,B.D. and Heiser,D.A. (2006) On the accuracy of statistical procedures in
Microsoft Excel 2007. Comput. Stat. Data Anal., 52, 4570–4578.
Shippy,R. et al. (2006) Using RNA sample titrations to assess microarray platform
performance and normalization techniques. Nat. Biotechnol., 24, 1123–1131.
Zeeberg,B.R. et al. (2004) Mistaken identiﬁers: gene name errors can be introduced
inadvertently when using Excel in bioinformatics. BMC Bioinformatics, 5, 80.
1548